In our current study, we have shown that TAK1 inhibitor OZ acts as an upstream regulator, transforming M1‐polarized microglia into M2 phenotype, rescuing the loss of oligodendrocytes, mediating inflammation, and increasing BDNF expression in CPZ‐induced demyelination mice model. This evidence concerns the gene MAP3K7 and Peripheral demyelination.